VEGFA and neoplasm: Indeed, bevacizumab treatment was initiated within 24 hours of the tumor cell inoculation in one of the first reports that demonstrated the potent efficacy of this VEGF antibody in a mouse model of human cancer, prior to the establishment of any tumor vasculature [29].